144 related articles for article (PubMed ID: 38632503)
1. Conditional survival and annual hazard of death in older patients with esophageal cancer receiving definitive chemoradiotherapy.
Chang X; Deng W; Yu R; Wang W
BMC Geriatr; 2024 Apr; 24(1):348. PubMed ID: 38632503
[TBL] [Abstract][Full Text] [Related]
2. Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.
Liu X; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Qi SN; Yang Y; Li YX
JAMA Netw Open; 2019 Mar; 2(3):e190194. PubMed ID: 30821826
[TBL] [Abstract][Full Text] [Related]
3. Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer.
Faiz Z; van Putten M; Verhoeven RHA; van Sandick JW; Nieuwenhuijzen GAP; van der Sangen MJC; Lemmens VEPP; Wijnhoven BPL; Plukker JTM
Ann Surg Oncol; 2019 Apr; 26(4):986-995. PubMed ID: 30719634
[TBL] [Abstract][Full Text] [Related]
4. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study.
Wani S; Drahos J; Cook MB; Rastogi A; Bansal A; Yen R; Sharma P; Das A
Gastrointest Endosc; 2014 Feb; 79(2):224-232.e1. PubMed ID: 24060519
[TBL] [Abstract][Full Text] [Related]
5. Mortality-Air Pollution Associations in Low Exposure Environments (MAPLE): Phase 2.
Brauer M; Brook JR; Christidis T; Chu Y; Crouse DL; Erickson A; Hystad P; Li C; Martin RV; Meng J; Pappin AJ; Pinault LL; Tjepkema M; van Donkelaar A; Weagle C; Weichenthal S; Burnett RT
Res Rep Health Eff Inst; 2022 Jul; 2022(212):1-91. PubMed ID: 36224709
[TBL] [Abstract][Full Text] [Related]
6. Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities.
Deng W; Yang Z; Dong X; Yu R; Wang W
Cancer Med; 2021 Jan; 10(2):659-674. PubMed ID: 33314798
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base.
Moreno AC; Verma V; Hofstetter WL; Lin SH
J Thorac Oncol; 2017 Jul; 12(7):1152-1160. PubMed ID: 28455149
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
9. Esophagectomy versus definitive chemoradiotherapy as initial treatment for clinical stage I esophageal cancer: a systematic review and meta-analysis.
Mei LX; Mo JX; Chen Y; Dai L; Wang YY; Chen MW
Dis Esophagus; 2022 Mar; 35(3):. PubMed ID: 34318324
[TBL] [Abstract][Full Text] [Related]
10. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis.
Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X
Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities, Outcomes, and Surgical Utilization among Hispanics with Esophageal Cancer: A Surveillance, Epidemiology, and End Results Program Database Analysis.
Gupta DR; Liu Y; Jiang R; Walid S; Higgins K; Landry J; McDonald M; Willingham FF; El-Rayes BF; Saba NF
Oncology; 2019; 97(1):49-58. PubMed ID: 31108497
[TBL] [Abstract][Full Text] [Related]
12. Trends in conditional overall survival of esophageal cancer: a population-based study.
Deng W; Yu R; Yang Z; Dong X; Wang W
Ann Transl Med; 2021 Jan; 9(2):102. PubMed ID: 33569404
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis.
Li J; Jia Y; Cheng Y; Wang J
Cancer Med; 2020 Jul; 9(14):5025-5034. PubMed ID: 32441890
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy and radiotherapy alone in patients with esophageal cancer aged 80 years or older based on the Comprehensive Registry of Esophageal Cancer in Japan.
Jingu K; Numasaki H; Toh Y; Nemoto K; Uno T; Doki Y; Matsubara H
Esophagus; 2020 Jul; 17(3):223-229. PubMed ID: 32088786
[TBL] [Abstract][Full Text] [Related]
15. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
[TBL] [Abstract][Full Text] [Related]
16. Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer.
van Holstein Y; Trompet S; van Deudekom FJ; van Munster B; de Glas NA; van den Bos F; Uit den Boogaard A; van der Elst MJT; van der Kaaij MAE; Neelis KJ; Langers AMJ; Slingerland M; Portielje JEA; Mooijaart SP
Acta Oncol; 2022 Apr; 61(4):459-467. PubMed ID: 35193449
[TBL] [Abstract][Full Text] [Related]
17. Impact of Frailty on Treatment Outcome in Patients With Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy.
Huang YH; Hung YS; Lai CC; Ho MM; Yeh KY; Yang C; Lu CH; Tseng CK; Tsang NM; Hung CY; Hsueh SW; Chang PH; Ho YW; Lin YC; Chou WC
Anticancer Res; 2021 Oct; 41(10):5213-5222. PubMed ID: 34593474
[TBL] [Abstract][Full Text] [Related]
18. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
19. Models for Predicting Early Death in Patients With Stage IV Esophageal Cancer: A Surveillance, Epidemiology, and End Results-Based Cohort Study.
Shi M; Zhai GQ
Cancer Control; 2022; 29():10732748211072976. PubMed ID: 35037487
[TBL] [Abstract][Full Text] [Related]
20. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]